Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II).
Trials. 2020 Jun 12;21(1):520. doi: 10.1186/s13063-020-04380-5.
Trials. 2020.
PMID: 32532356
Free PMC article.
Clinical Trial.
OBJECTIVES: To assess the safety and therapeutic effects of allogeneic human dental pulp stem cells (DPSCs) in treating severe pneumonia caused by COVID-19. ...Collect peripheral blood to detect the gene profile of mononuclear cells by using single-cell analyses. Collect p …
OBJECTIVES: To assess the safety and therapeutic effects of allogeneic human dental pulp stem cells (DPSCs) in treating severe pneumo …